These effects have been described in research settings as dose-related and mostly mild to moderate, although safety interpretation should always remain cautious because longer-term data is still being collected
It includes FDA-approved tablets like Rybelsus, compounded sublingual drops from pharmacies, and even newer formulations hitting the market
This was interesting because at that time it was assumed that the best way to treat patients with metabolic disorders was not to stimulate more glucagon because it raises blood sugar, but instead to block it
GLP-1 receptor agonists (GLP-1s)better known by brand names Ozempic, Wegovy, Mounjaro, or Zepbound are often referred to as miracle drugs. GLP-1s were originally developed to help regulate blood sugar in people with type 2 diabetes
Giving patients choices for their dosage helps to improve how well they respond to treatment
15, Issue 6, June 2025, Article 796)